Glaxo Smith Kline 58160084811 - AREXVY™… | USA MedPremium
AREXVY™ Respiratory Syncytial Virus Vaccine, Adjuvanted RSVPreF3 antigen/AS01E/PF Indicated for People 60 Years of Age and Older 120 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL
USAMP#87013225SKU: 58160084811AREXVY™
License Required
Product Spotlight
AREXVY™ (Respiratory Syncytial Virus Vaccine, Adjuvanted) suspension for intramuscular injection
AREXVY™ is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in individuals 60 years of age and older